Polymer-layered silicate nanocomposites in the design of antimicrobial materials by Nigmatullin, Rinat et al.
Polymer-layered silicate nanocomposites in the design
of antimicrobial materials
Rinat Nigmatullin Æ Fengge Gao Æ Viktoria Konovalova
Abstract A robust processing of polymers into antimi-
crobial materials is introduced using polymer/clay nano-
technology. Antimicrobial activity of commercially available
organoclays modified with cationic surfactants has been
screened in tests against gram-negative Escherichia coli
and gram-positive Staphylococcus aureus bacteria. Despite
the leaching biocidal surfactants, cell interactions with
organoclay surface have been identified to be responsible
for antimicrobial activity of organoclays. Distribution of
clay platelets within polymer matrix by melt extrusion
process resulted in polymer/clay nanocomposites active
against both gram-positive and gram-negative bacteria by
contact. The study discloses a much overlooked function of
organoclays modified with cationic surfactants for nano-
composite application, i.e., the ability of organoclays to
render polymer nanocomposites biocidal.
Introduction
In the past two decades, the idea of using layered clay min-
erals for polymer nanocomposite applications has flourished
resulting in the development of advanced materials with
improved mechanical, thermal, electrical, barrier, and opti-
cal properties [1, 2]. This progress was enabled by the
utilization of specially designed organophilic clays as
nanofillers in polymer composites [3, 4]. Conceptually, clay
modification intends the intercalation of organophilic sub-
stances into the interlayer space of the layered silicates to
weaken the interlayer interactions, increase the interlayer
spacing, and improve clay–polymer compatibility. This
allows macromolecules to penetrate into the interlayer space
during processing, leading to the separation of the individual
layers and uniform dispersion of the separated clay layers in a
polymer matrix. The versatile roles of organoclays in the
formation of polymer/clay nanocomposites and their
potential in improving a wide range of properties of poly-
mers demonstrate multifunctionality of clay minerals in
polymer composites.
Most of the organoclays for nanocomposite application
are produced through ion exchange of the metal cations
within the original clay with organophilic cations such as
quaternary ammonium salts. The important feature of these
organic modifiers is the presence of long hydrophobic
chain(s) in the organic cations [5, 6]. Such substances are
also highly effective against a broad spectrum of micro-
organisms and widely used as antimicrobial agents [7].
The use of mineral clays as biocide carriers has been
reported previously with the predominant application of
inorganic biocides, such as Ag, Cu, Zn, etc. [8–10] Bio-
cidal metals can be incorporated into the clay structure as
charge compensating ions via ion exchange. Alternatively,
nanoparticles of neutral metals can be formed inside the
clay gallery by the reduction of metals salts loaded into a
clay [9]. However, there are very few reports in the open
literatures concerning the antimicrobial activity of clays
loaded with organic biocides. The available information on
this so far includes the use of organoclays containing
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benzyl- or alkylammonium salts as antimicrobial additives
to topical cosmetic formulations [11] or in delivery systems
[12]; bacteria removal by clays modified with cetylpyri-
dinium in water treatment applications [13]; and the use of
cationic organic molecules, chlorhexidine acetate [14], and
chitosan [15, 16], which are well-known disinfectants, to
intercalate into layered silicates to produce antimicrobial
organoclays.
These sporadic researches into biocidal organoclays have
not yet involved their applications in polymer nanocom-
posites until recent research of polyurethane (PU)
nanocomposites for biomedical applications [15, 16]. It was
shown that the introduction of an organoclay into PU matrix
significantly suppressed biofilm formation on the material
surface exposed to the bacterial suspension [15]. At the same
time, these studies raised a concern of the applicability of
such composites as implantable biomaterials since nano-
composites were cytotoxic [15, 16]. Nevertheless such an
approach can open a new route toward much-sought mate-
rials with self-sterilising surfaces.
In this paper, the feasibility of using clay/polymer
nanotechnology has been further explored with a view to
developing polymer composites with antimicrobial prop-
erties. Clay/polymer nanocomposites have been prepared
by the melt processing with the use of commercially
available organoclays. Nanocomposites with platelets of
alkylammonium-modified clays dispersed in a polymer
matrix showed activity against both gram-positive and
gram-negative bacteria. This work reveals a new function
of organoclays in polymer/clay nanocomposite application
and opens up a new approach in the preparation of
advanced polymer materials with antimicrobial activity in
addition to enhanced physical and engineering properties.
Experimental
Materials
The organoclays were supplied by the Southern Clay
Products and were montmorillonites modified with the
following quaternary ammonium salts: dimethyl, benzyl,
hydrogenated tallow quaternary ammonium chloride
(Closite 10A, surfactant content 125 meq/100 g clay);
methyl, hydrogenated tallow, bis-2-hydroxyethyl quater-
nary ammonium chloride (Closite 30B, surfactant content
90 meq/100 g clay); dimethyl, dihydrogenated tallow
quaternary ammonium chloride (Closite 15A, surfactant
content 125 meq/100 g clay; Closite 20A, surfactant con-
tent 95 meq/100 g clay); methyl, dihydrogenated tallow
ammonium bisulfate (Cloisite 93A, surfactant content
90 meq/100 g clay). The nylon-6 studied was Ultramid
B3 purchased from BASF.
Nanocomposite preparation
Nylon-6/clay nanocomposites were prepared by melt
extrusion at 240 C using a 16 mm twin screw extruder
(length/diameter = 24/1) with a screw speed of 400 rpm
and feeding rate of 20%. Two series of nanocomposites
were produced using pre-dried and mixed formulations of
polyamide/clay: one series with content of each organoclay
5 wt.% and a second series of nylon-6/Cloisite 15A con-
taining 1, 2, 5 or 10 wt.% of organoclay. The extruded
strands were pelletized and dried in a vacuum oven at
80 C for 10 h before processing into square samples
(25 9 25 9 1 mm3) by injection moulding for the sub-
sequent XRD characterization and microbiological testing.
The temperature applied in the injection moulding was
270 C.
Clay and nanocomposite characterization
The XRD characterization of the organoclays and nano-
composites were carried out using a Philips XPert Pro XRD
(PANalytical, USA) with CuKa radiation at 40 kV and
30 mA.
Migration of surfactants from the clay and nanocom-
posites into an aqueous medium was studied as follows.
Two pieces of polymer plates with dimension
20 9 20 9 1 mm3 were immersed into 20 mL of demin-
eralized water (electrical conductivity 3 lS/cm) in a
centrifuge tube. The immersed nanocomposite samples
were maintained at ambient temperature for up to
3 months. In the study of organoclays, 0.2 g of organoclay
were suspended in 25 mL of demineralized water and
stirred for specified periods to obtain the release kinetics.
After stirring, the organoclay was filtered out using cellu-
lose filters with nominal pore size of 0.2 lm. A new
portion of organoclay was used for each separate kinetic
point. The electrical conductivity of the water in the tube
containing nanocomposite samples and filtrates was mea-
sured using a CDM210 Conductivity Meter (Radiometer
Analytical, France) equipped with CDC 745 conductivity
cells.
Evaluation of antimicrobial activity
Gram-negative E. coli BE and gram-positive S. aureus
CCM 209 bacteria strains were received from the Ukrai-
nian Collection of Microorganisms. The bacteria were
grown and maintained on Nutrient Agar No1 (Fluka).
Microbial suspensions were prepared in sterilized physio-
logical solution to reach a concentration of bacterial cells
of 107 CFU mL-1.
The MIC values of the organoclays were determined in
50 mL of organoclay suspension in sterile physiological
solution seeded with 1 mL of bacterial suspension
(*2 9 105 CFU mL-1). The concentrations of organoc-
lays ranged from 0.1 to 1.0 mg mL-1. After 3 h of shaking
the suspension at 30 C, 50-lL aliquots were spread on
nutrient agar in Petri dishes and incubated for 24 h at
30 C. Bacterial count after contact with unmodified
montmorillonite was used as a control. The MIC test was
repeated at least three times for each organoclay.
To study the antimicrobial activity of the nanocompos-
ites, 400 lL of the bacterial suspension were located in the
centre of a square piece of the material. The plastic piece
was covered with a similar piece and the sandwich
assembly was gently compressed to distribute bacterial
suspension evenly across the plastic surfaces. The assem-
bly was incubated for 24 h at 30 C. After incubation, the
two pieces were separated and placed such that nutrient
agar faced onto the seeded side. After 1 h, the plastic
pieces were removed, leaving bacterial cells on the nutrient
agar. The plates were incubated for 24 h at 30 C. Pieces of
pristine Nylon 6 were used for control. The plates were
examined for bacterial growth and compared with the
plates of control samples to classify the antimicrobial
activity in four categories: non-biocidal (++++ and
+++), low active (++), highly active (+), and strongly
biocidal (-). ‘‘+’’ is referred to viable cells and ‘‘-’’
referred to the absence of viable cells.
Results and discussion
Antimicrobial activity of organoclays
Depending on the molecular structure of the quaternary
salts, the tested organoclays can be divided into two
groups, i.e., organoclays with quaternary ammonium salts
possessing a single long tail of hydrogenated tallow
(Cloisite 10A, Cloisite 30B) and two long tails of hydro-
genated tallow (Cloisite 15A, Cloisite 20B, Cloisite 93A),
respectively. Initially, the antimicrobial activity of a series
of commercially available organoclays modified with
quaternary alkylammonium salts have been screened
against gram-positive E. coli. All the investigated orga-
noclays showed antimicrobial activity with Cloisite 10A
and Cloisite 30B being the most potent materials. The
minimal inhibitory concentration (MIC) of these two or-
ganoclays was 0.5 mg mL-1. The MIC of Cloisite 15A
was higher, 1.0 mg mL-1. The least potential organoclays
Cloisite 20A and Cloisite 93A cause complete inhibition of
bacterial growth at concentrations notably higher than
1.0 mg mL-1.
Such a behavior is likely associated with the biocidal
potentials of the ammonium salts. Cationic surfactants
containing one long tail are more efficient than those with
two long chains [17]. Moreover benzyl-containing surfac-
tants (as in Cloisite 10A) are more active than those
quaternary ammonium salts containing only aliphatic tails.
Therefore, generally, the observed antimicrobial efficien-
cies of organoclays are consistent with the biocidal activity
of the cationic surfactants used for clay modification.
However, since organoclays contain different amounts of
biocidal modifiers, direct correlation of the antimicrobial
activity of organoclays and corresponding surfactants is
inconclusive. For example, Cloisite 15A and Cloisite 20A
are two grades of clay modified with the same cationic
surfactant, with Cloisite 15A being more active, most
likely as a result of a higher concentration of biocide.
Since biocides are exchangeable cations in an organoclay
structure, they can migrate from the clay and thereby affect
bacteria as soluble antimicrobial agents. The electrical
conductivity of water-containing organoclay suspensions
was monitored to estimate the release of the ammonium salts
by surfactant-modified clays. As can be seen from Fig. 1, the
rate of electrolyte migration and equilibrium values of the
electric conductivity decreases in the following order:
Cloisite 10A [ Cloisite 30B & Cloisite 93A [ Cloisite
20A [ Cloisite 15A. Interestingly, organoclay Cloisite 15A
releases less biocide than Cloisite 20A despite having higher
surfactant loading. Nevertheless Cloisite 15A is more potent
against bacteria. This suggests that the antimicrobial activity
of an organoclay is not solely due to surfactants migrating
from the clay surface into the aqueous phase.
Zone inhibition tests (results are not presented) dem-
onstrated the formation of only small (if any) clear zones at
the edge of the organoclays, supporting the contention that
the antimicrobial activity of the organoclays is only par-
tially due to migrating biocides. It worth noting that
Dizman et al. [12] also indicated small inhibition zones for
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Fig. 1 Variation in electrical conductivity in the aqueous media after
contacting with organoclays showing the release of cationic surfac-
tants from the organoclays
fluoromicas modified with quaternary ammonium sub-
stances. To further elucidate, the role of migrating biocide
in the antimicrobial activity of organoclays, bacterial
growth was studied in physiological solutions used for the
elution of species migrating from the clay. In this experi-
ment, the most active organoclays, Cloisite 10A and
Cloisite 30B, were suspended in physiological solutions at
a concentration of 0.5 mg mL-1 corresponding to their
MIC value. After 2-hour stirring, the organoclays were
filtered out and the filtrate was inoculated with E. coli
(105 CFU mL-1) and incubated for 20 h. The results
obtained from bacterial count showed that the reduction of
viable cells attained in the filtrate was 15%, while practi-
cally complete inhibition of bacteria growth ([95%) was
observed in the clay suspension in the similar experiment.
These observations indicate that biocide migration is
only partially responsible for the antimicrobial activity of
organoclays. An organoclay with immobilized cationic
surfactants can itself act as a solid biocide killing bacteria
by contact. Previously, other research groups [13, 18] also
postulated the surface contact mechanism for solid polymer
materials containing cationic surfactants, which were loa-
ded by ion exchange. Similar to our observation, in these
studies, although the concentrations of surfactant migrated
from such surfaces were well below the MIC of the bio-
cidal surfactant, the solid materials were effective in the
inhibition of bacterial growth.
Therefore, it appears that at least two mechanisms are
responsible for the antimicrobial activity of the organoc-
lays, i.e., activity of surfactants released from the clay and
the action of the solid surface. Although the details of the
latter mechanism have not yet been clarified, it may be
reasonable to speculate that intimate contacts between a
bacterial cell and antimicrobial surface may be crucial to
affect the cell. These interactions are dependent on the
surface properties of the cell and organoclay and, conse-
quently, on supramolecular organization of the surfactants
on the surface of the clay layers.
Depending on the surfactant content in an organoclay,
long carbon chains of surfactant can be arranged between
the clay sheets as mono- or bilayers parallel to the clay
surface or as pseudotrimolecular layers or paraffin com-
plexes. The surface properties and hydrophilic/hydrophobic
balance of organoclays are determined by the supramolec-
ular structure of the surfactants. Most hydrophobic orga-
noclays are formed when the surfactant content was
110–130% with respect to cation exchange capacity (CEC)
of the clay [19]. The surfactant content in Cloisite 15A lies
in this range and therefore surfactant migration from Closite
15A is slower than that from more hydrophilic Cloisite 20A.
Somehow supramolecular organization in Cloisite 15A is
more efficient in rendering the clay surface antimicrobial
than in Cloisite 20A.
Antimicrobial activity of polymer nanocomposites
Following on from these observations of antimicrobial
activity in the commercially available organoclays studied
herein, a series of clay/nylon 6 nanocomposites have been
prepared with the use of these organoclays to investigate
the feasibility of rendering thermoplastics biocidal apply-
ing established polymer/clay nanotechnology.
It is widely recognized that the molecular structure and
content of surfactants in clay are crucial in clay exfoliation
in a polymer matrix. XRD analysis of the nanocomposites
produced by melt extrusion showed that in all the nylon 6
nanocomposites the basal spacing between adjacent clay
layers increased with respect to the corresponding original
organoclay (Table 1). The structures formed are essentially
intercalated. The increase in d-spacing is greater for the
composites produced from the organoclays containing
surfactants with two long tails. However for the organoc-
lays containing the same type of surfactant but different
content, Cloisite 15A and 20A, the clay with higher sur-
factant content (Cloisite 15A) resulted in a smaller increase
in d-spacing compared with Cloisite 20A leveling the final
values of d-spacing in the two nanocomposites, approxi-
mately 35A.
Nylon-6 and montmorillonite have relatively good
affinity and polyamide/clay interactions are considered to
be preferential compared to interactions between the
polymer and hydrophobic surfactant tails [5]. Thus, over-
loading organoclay with surfactant sterically blocks the
silicate surface and thereby diminishes polyamide/clay
contacts. As a result, a smaller amount of polymer inter-
calates into the interlayer spacing of Cloisite 15A than
Cloisite 20A.
Since combining a polyamide and an organoclay to form
a nanocomposite is not accompanied with covalent binding
of the surfactants, these hybrid materials are also expected
to release surfactants. This hypothesis was examined by
measuring the electrical conductivity of water containing a
fixed sample size of immersed nanocomposite. As shown
in the Fig. 2, all the composite materials exhibit leaching.
Similarly migration of cationic surfactant from PU
Table 1 Basal spacing of organoclays and corresponding Nylon 6
nanocomposites
Organoclay d001 of
organoclays (A˚)
d-spacing gain in
nanocomposite (A˚)
Cloisite Na+ 11.7 –
Cloisite 10A 18.4 3.6
Cloisite 30B 17.9 5.2
Cloisite 15A 30.4 4.8
Cloisite 20A 21.5 13.0
Cloisite 93A 23.5 6.1
nanocomposites has been recently demonstrated using
liquid chromatography–mass spectroscopy and cytotoxicity
tests of leachates [20].
Naturally, migration of surfactants from the polymer
composite is drastically slowed compared with the corre-
sponding release rate of the surfactants from the respective
organoclays alone. Similar to the organoclay results,
leaching of the most hydrophilic surfactants (used for the
preparation of Cloisite 10A and Closite 30B) was quicker
for the corresponding polymer/clay composites. At the
same time, surfactant release from the composite with
Cloisite 93A is slower than that from the composite pro-
duced using Closite 20A, despite the fact that an opposite
trend was observed with the counterpart organoclays. Such
leaching behavior may be associated with the bonding
strength of the surfactants on the surface of clay and the
nano-structure of the composites.
The bactericidal activity of the polymer/clay nanocom-
posites produced was tested against gram-positive
S. aureus and gram-negative E. coli by the determination
of the viability of the cells spread over the flat surface of
composite plates. A semi-quantitative method has been
applied for the characterization of antimicrobial activity of
solid polymer surfaces. The method classifies the antimi-
crobial activity of the materials into four categories:
non-biocidal (++++ and +++), low active (++), highly
active (+), and strongly biocidal (-) with ‘‘+’’ referring to
the extent of viable cells and ‘‘-’’ referring to the absence
of viable cells. As can be seen from Table 2, for com-
posites containing 5% of organoclays, the material with
Cloisite 30B was strongly biocidal against both the gram-
positive and gram-negative bacteria tested. Other com-
posites showed high activity against E. coli and moderate
activity against S. aureus. However the nanocomposite
with Cloisite 10A was highly active against S. aureus.
Antimicrobial activity of the nanocomposites increases
with an increase in the organoclay loading. For example, an
increase in the content of organoclay Cloisite 15A in the
composites from 5% to 10%, led to a nanocomposite which
was classified as strongly biocidal against E. coli (Table 2).
Taking into account the slow migration rate of the
biocides from the polymer/clay nanocomposites, it is rea-
sonable to assume that the antimicrobial action of the
composites is dominated by the solid surface mode rather
than the migration mode. There are some indications that
the antimicrobial activity of polymer/clay nanocomposites
depends on supramolecular organization of the surfactants
and the nano-structure of the composites. For example, the
composite produced from Cloisite 30B was the most active
material in spite of it having the lowest surfactant content
in the organoclay, i.e., 90% of surfactant with respect to
CEC. Only Cloisite 93A has similar content of surfactant.
Although Cloisite 10A is as active as Cloisite 30B, and
releases surfactant faster, its nanocomposite is less efficient
than the composite containing Cloisite 30B. These obser-
vations suggest that the antimicrobial activity of clay/
polymer nanocomposites is a function of not only the
biocidal activity of the surfactants, but also the nano-
structure of the composites. Synergy effects may also be
involved. Our current research is focused on gaining more
insights into these relations.
It is worth noting that test bacteria studied herein have
different abilities to grow on the surface of pristine nylon-
6. Gram-positive S. aureus is more prolific than E. coli and
spread evenly across the surface. This makes it difficult to
discriminate the individual colonies of S. aureus on the
surface of pristine nylon-6. Since the cell viability was
estimated by reference to pristine nylon-6, differences in
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Fig. 2 Variation of electrical conductivity in aqueous media after
contacting with nanocomposites showing the release of cationic
surfactants from the nanocomposites
Table 2 Antimicrobial activity of polyamide/clay nanocomposites containing 5 wt.% of different Cloisite organoclays
Bacteria Nylon 6 (control) Cloisite 10A Cloisite 30B Cloisite 15Aa Cloisite 20A Cloisite 93A
E. coli +++ + - +++ (1%) + +
++ (2%)
+ (5%)
- (10%)
S. aureus ++++ + - ++ ++ ++
a Content of Cloisite 15A in nanocomposites is shown in parentheses
cell growth on control (bare polyamide) samples can lead
to a misinterpretation of the susceptibility of different cells
to the antimicrobial action of the polymer/clay nanocom-
posites. Therefore the reported higher grades of biocidal
activity for nanocomposites against E. coli (Table 2) do
not necessarily mean that they are more active against
gram-negative bacteria. From this point of view, further
investigations are required to clarify the antimicrobial
efficiency of the nanocomposites against gram-positive and
gram-negative bacteria.
Conclusions
This study demonstrates a significantly overlooked func-
tion of organoclays modified with cationic surfactants for
nanocomposite application, i.e., the ability of organoclays
to render polymer nanocomposites biocidal. This finding is
very significant and opens the way for the highly appraised
polymer/clay nanotechnology to enable robust processing
of polymers into antimicrobial materials, with the sub-
stantial additional benefits of improved engineering
properties. This approach provides an alternative to surface
modification or coating technologies in the production of
self-sterilizing surfaces. However, the present study toge-
ther with the reports of another research group [20, 21]
show that the biocidal modifiers migrate from the clay and
nanocomposites. Therefore, the existing polymer/clay
technology, based on commercially available organoclays,
can be applied only in fields where surfactant migration is
acceptable, for example, textiles, furniture, electronics, etc.
Prevention of biocide migration will widen the applica-
bility of antimicrobial clay/polymer nanocomposites. This
problem is addressed in our current research on the
development of non-leaching biocidal organoclays.
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